Drug Shortage Report for TEVA-ACEBUTOLOL

Last updated on 2019-08-20 History
Report ID 50023
Drug Identification Number 02204517
Brand name TEVA-ACEBUTOLOL
Common or Proper name ACEBUTOLOL
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) ACEBUTOLOL
Strength(s) 100MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C07AB
ATC description BETA BLOCKING AGENTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2018-05-30
Estimated end date Unknown
Actual end date 2019-05-30
Shortage status Resolved
Updated date 2019-08-20
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2019-08-20 French Compare
v8 2019-08-20 English Compare
v7 2018-07-30 French Compare
v6 2018-07-30 English Compare
v5 2018-05-31 English Compare
v4 2018-05-30 French Compare
v3 2018-05-30 English Compare
v2 2018-05-22 French Compare
v1 2018-05-22 English Compare

Showing 1 to 9 of 9